
SBC Medical Group Holdings Incorporated: updates and filings
Price
$6.12
November 17, 2026Market cap $628M
What Ploutos Investor adds for SBC Medical Group
Part of Ploutos Investor, €9.99 a month
- The full history: 3 fiscal years, from 2023
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 13, 2026next Feb 12, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
March 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 13, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 13, 2026Results of operations, Regulation FD disclosureForm8-K
- Aug 13, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 13, 2026Results of operations, Regulation FD disclosureForm8-K
- Jul 14, 2026Delisting notice, change to shareholders' rights, amended articles or bylaws, shareholder voteForm8-K
- May 28, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- May 28, 2026Additional annual meeting materialFormDEFA14A
- May 28, 2026Annual meeting proxy statementFormDEF 14A
- May 20, 2026Officer or director changeForm8-K
- May 15, 2026Preliminary proxy statementFormPRE 14A
- May 14, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 14, 2026Results of operations, Regulation FD disclosureForm8-K
- Apr 30, 2026Annual report (amendment)for the period to Dec 31, 2025Form10-K/A
- Apr 23, 2026Material agreement enteredForm8-K
- Apr 21, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Mar 27, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 27, 2026Results of operations, Regulation FD disclosure, other material eventsForm8-K
- Mar 13, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Mar 10, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Jan 5, 2026Regulation FD disclosure, other material eventsForm8-K
- Dec 31, 2025Regulation FD disclosure, other material eventsForm8-K
- Dec 30, 2025FilingFormEFFECT
- Dec 29, 2025Correspondence with the SECFormCORRESP
- Dec 29, 2025Shelf registration for future offeringsFormS-3
- Dec 15, 2025Other material eventsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 13, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 13, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Aug 13, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 13, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jul 14, 2026 | 8-K | Delisting notice, change to shareholders' rights, amended articles or bylaws, shareholder vote | Document |
| May 28, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| May 28, 2026 | DEFA14A | Additional annual meeting material | Document |
| May 28, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| May 20, 2026 | 8-K | Officer or director change | Document |
| May 15, 2026 | PRE 14A | Preliminary proxy statement | Document |
| May 14, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 14, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Apr 30, 2026 | 10-K/A | Annual report (amendment)for the period to Dec 31, 2025 | Document |
| Apr 23, 2026 | 8-K | Material agreement entered | Document |
| Apr 21, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Mar 27, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 27, 2026 | 8-K | Results of operations, Regulation FD disclosure, other material events | Document |
| Mar 13, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Mar 10, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Jan 5, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Dec 31, 2025 | 8-K | Regulation FD disclosure, other material events | Document |
| Dec 30, 2025 | EFFECT | Filing | Document |
| Dec 29, 2025 | CORRESP | Correspondence with the SEC | Document |
| Dec 29, 2025 | S-3 | Shelf registration for future offerings | Document |
| Dec 15, 2025 | 8-K | Other material events | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jun 14, 2022.
The full analysis
What do SBC Medical Group's filings show?
The filings are where every one of SBC Medical Group's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.